Renaissance Technologies’s Belite Bio BLTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.57M Sell
32,800
-22,963
-41% -$3.73M 0.01% 1399
2026
Q2
$8.59M Buy
55,763
+3,763
+7% +$577K 0.01% 1145
2026
Q1
$8.29M Buy
+52,000
New +$8.74M 0.01% 1069
2025
Q4
– Sell
-2,812
Closed -$208K – 3261
2025
Q3
$208K Sell
2,812
-1,488
-35% -$97.7K ﹤0.01% 3125
2025
Q2
$248K Buy
+4,300
New +$262K ﹤0.01% 3099
2024
Q1
– Sell
-4,900
Closed -$224K – 3712
2023
Q4
$224K Buy
+4,900
New +$188K ﹤0.01% 3093

Other funds holding BLTE

Renaissance Technologies's BLTE Position: Q3 2026 in Review

Renaissance Technologies reduced its Belite Bio (BLTE) stake by 41% in Q3 2026, selling an estimated $3.73M and leaving 32,800 shares worth $5.57M. The position accounts for 0.01% of the portfolio, ranked #1399.

Renaissance Technologies first reported a position in BLTE in Q4 2023 and has held it in 6 quarters since. The position peaked at $8.59M in Q2 2026. 96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.

  • Renaissance Technologies held 32,800 shares of Belite Bio worth $5.57M as of Q3 2026.
  • Renaissance Technologies sold 22,963 Belite Bio shares in Q3 2026, an estimated $3.73M.
  • Belite Bio made up 0.01% of Renaissance Technologies's portfolio in Q3 2026, its #1399 holding.
  • Renaissance Technologies first reported a position in Belite Bio in Q4 2023 and has held it in 6 quarters since.
  • Renaissance Technologies's Belite Bio position peaked at $8.59M in Q2 2026.
  • 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.

Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.